MedTrace Logo

β-Glucans and the Metabolic Syndrome - a Human Intervention Study Under BEST

NCT01317264 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2011-03-17

No results posted yet for this study

Summary

The aim of this study is to investigate the potential disease preventive effects of β-glucans from oat and barley.

Conditions

  • Healthy

Interventions

OTHER

no β-glucan

daily consumption of non-β-glucan containing milk drinks together with the 3 main meals for 21 days

OTHER

oat β-glucan

daily consumption of 5g of oat β-glucan in the form of milk drinks with the 3 main meals for 21 days

OTHER

barley β-glucan

daily consumption of 5g β-glucan extracted from the barley-mutant mother "Bomi" in the form of milk drinks with the 3 main meals for 21 days

OTHER

mutant-barley β-glucan

daily consumption of 5g β-glucan extracted from the high β-glucan barely mutant "lys. 5.f" in the form of milk drinks with the 3 main meals for 21 days

Sponsors & Collaborators

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Arne Astrup, Professor · Department of human nutrition, University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-10-31
Completion
2011-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01317264 on ClinicalTrials.gov